Publication | Closed Access

Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms

AdhdYoung AdultsLow-dose VenlafaxinePsychiatrySyndromic AutismNeuropharmacologyAutismSocial SciencesAttention Deficit/hyperactivity DisordersMedicinePsychopathologyNeurodiversity